BetterLife FSHD: A Patient-driven Health and Research Platform

计划入组 5,000 人 · 首次发布于 2026 年 2 月 13 日

Pharma-Pen (Formerly Innoject) Auto-injectory TIV

首次发布于 2006 年 6 月 12 日

Bioequivalence Study of Vildagliptin From Gliptus 50 mg Tablet (EVA Pharma, Egypt) and Galvus 50 mg Tablet (NOVARTIS PHARMA, GERMANY)

计划入组 24 人 · 首次发布于 2016 年 6 月 29 日

Interferon alpha 2b inhalation (Altum Pharmaceuticals/BetterLife Pharma)

Etanercept(Enbrel, Eticovo, Benepali, Erelzi, Nepexto)

Rx

Thalidomide inhalation (Vicore Pharma)

Bioprojet Pharma

Belgium

ACASTI PHARMA INC

United States

Innate Pharma, Inc.

United States

BetterLife Pharma Secures USPTO Patent for Non-Hallucinogenic LSD Derivative BETR-001

BetterLife Pharma's BETR-001 Shows Promise as Non-Hallucinogenic Neuroplastogen for Psychiatric Disorders

BetterLife Pharma Appoints Mahan Chehrenama, DO, as Chief Medical Officer to Lead BETR-001 Toward Migraine IND